Evidence map›Paper›PMID 40861535›Full record

ArticleCureus2025

A Novel Finding of Retinal Neovascularization Secondary to Chronic Central Serous Chorioretinopathy.

Chathuranka De Silva, Ajay Kotagiri

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Chathuranka De SilvaOphthalmology, Royal Victoria Infirmary, Newcastle upon Tyne, GBR.
Ajay KotagiriOphthalmology, Sunderland Eye Infirmary, Sunderland, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a rare case of a 59-year-old male with bilateral chronic multifocal central serous chorioretinopathy (CSCR) who developed retinal neovascularization (RNV). This patient had been under review for CSCR for several years before developing a new frond of RNV in his right eye. Comprehensive investigations, including fundus fluorescein angiography, were performed to exclude alternative causes such as diabetic retinopathy, vascular occlusion, or retinal vasculitis. He was treated with three intravitreal injections of bevacizumab and received sectoral panretinal photocoagulation laser with good response and regression of the vessel appearance.

Indexed as

anti-vegf treatmentcentral serous chorioretinopathycomplicationpan-retinal photocoagulation laserretinaretinal neovascularization

Identifiers

PMID40861535
PMCPMC12376936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.